EA200970687A1 - Левозимендан для применения в лечении хронического заболевания клапанов - Google Patents
Левозимендан для применения в лечении хронического заболевания клапановInfo
- Publication number
- EA200970687A1 EA200970687A1 EA200970687A EA200970687A EA200970687A1 EA 200970687 A1 EA200970687 A1 EA 200970687A1 EA 200970687 A EA200970687 A EA 200970687A EA 200970687 A EA200970687 A EA 200970687A EA 200970687 A1 EA200970687 A1 EA 200970687A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- treatment
- simendan
- levo
- valves
- chronic disease
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Изобретение относится к способу лечения хронического заболевания клапанов (CDV) у животных, в частности у собак, включающему введение субъекту, нуждающемуся в таком лечении, эффективного количества левозимендана или его фармацевтически приемлемой соли. Было показано, что левозимендан значительно понижает летальность и значительно повышает качество жизни собак, страдающих хроническим заболеванием клапанов.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US88069207P | 2007-01-17 | 2007-01-17 | |
PCT/FI2008/000004 WO2008087248A1 (en) | 2007-01-17 | 2008-01-17 | Levosimendan for use in treating chronic valvular disease |
Publications (2)
Publication Number | Publication Date |
---|---|
EA200970687A1 true EA200970687A1 (ru) | 2009-12-30 |
EA015888B1 EA015888B1 (ru) | 2011-12-30 |
Family
ID=39183147
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200970687A EA015888B1 (ru) | 2007-01-17 | 2008-01-17 | Левозимендан для применения в лечении хронического заболевания клапанов |
Country Status (10)
Country | Link |
---|---|
US (1) | US20100286150A1 (ru) |
EP (1) | EP2117551A1 (ru) |
JP (1) | JP2010516659A (ru) |
AU (1) | AU2008206903B2 (ru) |
BR (1) | BRPI0806588A2 (ru) |
CA (1) | CA2675176A1 (ru) |
EA (1) | EA015888B1 (ru) |
NZ (1) | NZ578228A (ru) |
WO (1) | WO2008087248A1 (ru) |
ZA (1) | ZA200904726B (ru) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20190259482A1 (en) * | 2018-02-20 | 2019-08-22 | Mediedu Oy | System and method of determining a prescription for a patient |
US11969424B2 (en) | 2019-12-16 | 2024-04-30 | Tenax Therapeutics, Inc. | Levosimendan for treating pulmonary hypertension with heart failure with preserved ejection fraction (PH-HFpEF) |
RU2745653C1 (ru) * | 2020-06-11 | 2021-03-30 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Московская государственная академия ветеринарной медицины и биотехнологии - МВА имени К.И. Скрябина" (ФГБОУ ВО МГАВМиБ - МВА имени К.И. Скрябина) | Способ лечения собак, больных эндокардиозом митрального клапана |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2251615B (en) * | 1991-01-03 | 1995-02-08 | Orion Yhtymae Oy | (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazono]pro panedinitrile |
FI20000577A0 (fi) * | 2000-03-13 | 2000-03-13 | Orion Yhtymae Oy | Pyridatsinyylifenyylihydratsoneja |
FI20040675A0 (fi) * | 2004-05-12 | 2004-05-12 | Orion Corp | Menetelmä sydämen hypertrofian hoitoon ja estoon |
-
2008
- 2008-01-17 US US12/523,228 patent/US20100286150A1/en not_active Abandoned
- 2008-01-17 WO PCT/FI2008/000004 patent/WO2008087248A1/en active Application Filing
- 2008-01-17 EA EA200970687A patent/EA015888B1/ru not_active IP Right Cessation
- 2008-01-17 NZ NZ578228A patent/NZ578228A/en not_active IP Right Cessation
- 2008-01-17 JP JP2009545958A patent/JP2010516659A/ja active Pending
- 2008-01-17 AU AU2008206903A patent/AU2008206903B2/en not_active Expired - Fee Related
- 2008-01-17 BR BRPI0806588-8A patent/BRPI0806588A2/pt not_active IP Right Cessation
- 2008-01-17 CA CA002675176A patent/CA2675176A1/en not_active Abandoned
- 2008-01-17 EP EP08701693A patent/EP2117551A1/en not_active Withdrawn
-
2009
- 2009-07-06 ZA ZA200904726A patent/ZA200904726B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
EP2117551A1 (en) | 2009-11-18 |
JP2010516659A (ja) | 2010-05-20 |
NZ578228A (en) | 2012-01-12 |
EA015888B1 (ru) | 2011-12-30 |
CA2675176A1 (en) | 2008-07-24 |
WO2008087248A1 (en) | 2008-07-24 |
AU2008206903B2 (en) | 2012-07-05 |
US20100286150A1 (en) | 2010-11-11 |
AU2008206903A1 (en) | 2008-07-24 |
ZA200904726B (en) | 2010-04-28 |
BRPI0806588A2 (pt) | 2014-05-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2009000385A (es) | Acil-anilidas sustituidas y metodos de uso de las mismas. | |
UA116871C2 (uk) | СПОСІБ ЛІКУВАННЯ МІЄЛОДИСПЛАСТИЧНОГО СИНДРОМУ, ТАЛАСЕМІЇ ТА СЕРПОПОДІБНО-КЛІТИННОЇ АНЕМІЇ ЗА ДОПОМОГОЮ ЗАСТОСУВАННЯ АНТАГОНІСТА АКТИВІНУ ПОЛІПЕПТИДУ ActRII | |
EA200970933A1 (ru) | Способы лечения или профилактики рвоты с помощью агентов, усиливающих секрецию гормона роста | |
GT200800098A (es) | Anticuerpos anti mn y metodos para su utilización | |
EA200801842A1 (ru) | Антитела против бета-амилоидного пептида | |
MX2009001962A (es) | Acilanilidas substituidas y metodos de uso de las mismas. | |
EA200870385A1 (ru) | Ингибирование токсичности альфа-синуклеина | |
EA201000865A1 (ru) | Комбинация ингибиторов протеинтирозинфосфатазы и гормона роста человека, предназначенная для лечения атрофии мышц и родственных нарушений | |
NO20074999L (no) | Metode og preparat for behandling av perifere vaskulaere sykdommer | |
MX338447B (es) | Tratamiento para diabetes en pacientes inapropirados para terapia con metformina. | |
EA201100609A1 (ru) | Способы лечения воспаления | |
WO2007087468A3 (en) | Adiponectin for treatment of various disorders | |
BRPI0812298A2 (pt) | sequência de aminoácidos direcionada contra rankl e polipeptídeos compreendendo a mesma para o tratamento de transtornos e doenças ósseas. | |
GT200600160A (es) | Tratamiento del dolor | |
EA200801033A1 (ru) | Применение олигоуронатов для лечения повышенной вязкости слизи | |
NO20082536L (no) | Behandling av kronisk nyresykdom(CKD)individer ved bruk av lantanforbindelser | |
BRPI0815752A2 (pt) | Mimético de peptídeo tipo nap ou mimético de peptídeo tipo sal, composição farmacêutica, e, método para tratar ou prevenir doenças. | |
BRPI0909447A2 (pt) | Composição, métodos para tratar um indivíduo humano ou animal em necessidade de tal tratamento e para matar ou inibir o crescimento de microrganismos suscetíveis, e, uso de uma composição | |
EA200802412A1 (ru) | Терапевтические комбинации для сопровождающихся болью медицинских состояний | |
WO2006098979A3 (en) | Aminopterin dosage forms and methods for inflammatory disorders | |
IS8162A (is) | Aðferð til að meðhöndla eða fyrirbyggja neðri þvagvegaeinkenni | |
EA201270071A1 (ru) | Способ лечения пациента, нуждающегося в аспириновой терапии | |
WO2006071456A3 (en) | Inhibition of hsp27 phosphorylation for treatment of blistering disorders | |
BRPI0920170A2 (pt) | métodos para diminuir a quantidade de partículas ldl pequenas e densas e de níveis de triglicerídeos e ldl no sangue em um humano, e para identificar um indivíduo candidato para tratamento com um composto ou um sal, prodroga ou isômero do mesmo, composto ou um sal, prodroga ou isômero do mesmo, e método. | |
EA200970687A1 (ru) | Левозимендан для применения в лечении хронического заболевания клапанов |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG MD TJ TM |
|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): RU |